학술논문
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial
Document Type
Article
Author
West, Howard; McCleod, Michael; Hussein, Maen; Morabito, Alessandro; Rittmeyer, Achim; Conter, Henry J; Kopp, Hans-Georg; Daniel, Davey; McCune, Steven; Mekhail, Tarek; Zer, Alona; Reinmuth, Niels; Sadiq, Ahad; Sandler, Alan; Lin, Wei; Ochi Lohmann, Tania; Archer, Venice; Wang, Lijia; Kowanetz, Marcin; Cappuzzo, Federico
Source
In The Lancet Oncology July 2019 20(7):924-937
Subject
Language
ISSN
1470-2045